RESEARCH STUDIES & Clinical Trials

Clinical Trial ID: NCT04267848 Integration Of Immunotherapy Into Adjuvant Therapy For Resected NSCLC: Alchemist Chemo-IO

Status

Open

Description

Objective

Treatment

Conditions

Other

Phases

III

Therapies

Drugs

Age Group

Adult

Main Investiagtor

Vu, John

Practice

Lung

Scope

National

Participating Institutions

Eligibility

Nct ID Number

NCT04267848

Secondary Trial ID Number

A081801

Keywords

Treatment

More Information

clinicaltrials.gov

“The support team gave not only me but my family a sense of peace.”

—David Smith, Patient

At Baptist MD Anderson, you can rely on our cancer experts to deliver the complex, coordinated care needed to address your condition. Learn more about Patricia’s story as well as others from our patients.